by Aucentra Admin | Nov 11, 2022 | Aucentra News
Aucentra Therapeutics is pleased to announce the appointment of Dr David Fuller as ‘Chief Medical Officer’ and a member of the executive management team commencing 16 November 2022. Dr Fuller will lead the company’s Australia and global clinical development at a...
by Aucentra Admin | Nov 10, 2022 | Aucentra News
Aucentra is very excited to announce our most recent addition to the growing team – Ms Maria Maieli, Chief Financial Officer. Maria is an accomplished executive with extensive experience in commercially driven industries having worked 30 years in a combination of...
by Aucentra Admin | Jun 28, 2022 | Aucentra News
ADELAIDE, Australia- 12 May 22 On 12th May 2022, Professor Shudong Wang, invited by the University of South Australia Dean of Research Clinical Health & Sciences, held a live webinar to discuss her ground-breaking pancreatic cancer research drug discovery and...
by Aucentra Admin | Mar 28, 2022 | Aucentra News
ADELAIDE, Australia – 25/03/2022 Aucentra Therapeutics (https://www.aucentra.com/) is pleased to announce the appointment of Mr. Joe Bayer as Chief Executive Officer to lead the company in its growth and commercial phase. Aucentra Therapeutics is a clinical stage...
by Aucentra Admin | Feb 25, 2022 | Aucentra News
24 February 2022 Adelaide, Australia- Aucentra Therapeutics is pleased to announce that it has received regulatory approval to progress to a Phase 1a/b clinical trial of Auceliciclib (AU3-14) in combination with Temozolomide for recurrent/refractory GBM patients....
Recent Comments